Session 6 - Process excellence and high quality manufacturing

Wednesday, November 6, 2013: 8:00 AM-11:30 AM
Islands Ballroom F-J (Marriott Marco Island)
Convener:
Tiffany D. Rau - Eli Lilly, Lake Charles, LA
Co-Convener:
Stuart M. Stocks - Novozymes A/S, Bagsværd,



8:00 AM
S34
Rational design of chemically-defined microbial fermentation media: a balanced approach
Corey Dodge1, Robert Binkley1, Jose Cepeda1, Kangfu Gu2, Kelvin Wong1 and Martin Mayhew2, (1)Research and Development, Verenium Corporation, San Diego, CA, (2)Bioprocess Development, Verenium Corporation, San Diego, CA
8:30 AM
S35
Challenges for stem cell bioprocessing- scale-up or scale-out?
Chris J. Hewitt, Centre for Biological Engineering, Loughborough University, Leicestershire, United Kingdom
9:00 AM
S36
Large Scale Fermentation Processes in the Context of Globally Distributed Production
Christopher McDowell, Novozymes Blair Inc. Blair, Nebraska, USA., Novozymes North America, Franklinton, NC and Rutger Douma, Novozymes, A/S, Bagsvaerd, Denmark
9:30 AM
Break
10:00 AM
S37
Fermentation scale-down: A view from industrial practice
Henk Noorman, Fermentation, DSM Biotechnology Center, Delft, Netherlands
10:30 AM
S38
A Novel Bacterial Contamination in Cell Culture Manufacturing
Robert D. Kiss, Late Stage Cell Culture Process Development, Genentech, Inc., South San Francisco, CA
11:00 AM
S39
Process Excellence Starting in Development
David Walsh, Lonza Biologics, Inc., Hopkinton, MA
See more of: Invited Oral Papers
<< Previous Session | Next Session >>